Tivic Health Systems, Inc. Enters Side Letters for $50,000 Series B and $4,717,717.61 Series C Preferred Stock Closings

Tivic Health Systems, which filed under the name Valion Bio, is party to a Securities Purchase Agreement with 3i, LP, dated April 29, 2025 and amended December 9, 2025. The excerpt says the agreement provides for the purchase and sale of up to 8,400 shares of Series B Non-Voting stock; the text is truncated, so additional terms and implications are not available.